福瑞股份因未依法履行其他职责等违规行为被证监会责令改正

Core Points - The company, Inner Mongolia Furu Medical Technology Co., Ltd., has been ordered to rectify its information disclosure violations by the China Securities Regulatory Commission (CSRC) [1] Group 1: Violations Identified - The company has inadequate internal control over its overseas subsidiaries, failing to establish necessary risk management systems and supervision protocols, which violates the Corporate Governance Guidelines [2] - Revenue recognition practices are not compliant, with premature revenue recognition leading to inaccuracies in financial reporting for multiple periods, violating accounting standards [3] - The company did not properly estimate variable consideration in sales contracts, resulting in full revenue recognition without appropriate adjustments for discounts and rebates, which is against accounting regulations [3] Group 2: Penalties Imposed - The company is subject to corrective supervision measures and has received a warning letter, which will be recorded in the securities and futures market integrity archive [4]